Telos Capital Management Inc. Has $1.45 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Telos Capital Management Inc. lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,999 shares of the financial services provider’s stock after buying an additional 209 shares during the period. Telos Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $1,454,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of IBB. SPC Financial Inc. grew its position in iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management grew its position in iShares Biotechnology ETF by 2.7% during the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after acquiring an additional 76 shares during the last quarter. Chicago Partners Investment Group LLC grew its position in iShares Biotechnology ETF by 2.5% during the 4th quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock worth $510,000 after acquiring an additional 94 shares during the last quarter. Capital Investment Advisors LLC grew its position in iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after acquiring an additional 99 shares during the last quarter. Finally, Magnus Financial Group LLC boosted its position in iShares Biotechnology ETF by 0.8% in the 4th quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock valued at $1,714,000 after buying an additional 104 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 1.2 %

Shares of IBB opened at $140.56 on Friday. The business’s fifty day moving average price is $136.29 and its two-hundred day moving average price is $141.47. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.